cobicistat 150 MG / elvitegravir 150 MG / emtricitabine 200 MG / tenofovir alafenamide 10 MG Oral Tablet [Genvoya]
RxNorm concept 1721619, branded drug (sbd). Prescribable name: Genvoya 150 MG / 150 MG / 200 MG / 10 MG Oral Tablet.
- RxCUI
- 1721619
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1721619 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Genvoya (cobicistat 150 MG / elvitegravir 150 MG / emtricitabine 200 MG / tenofovir alafenamide 10 MG (as tenofovir alafenamide fumarate 11.2 MG)) Oral Tablet
Related concepts
- emtricitabine 200 MG (SCDC, consists of)
- cobicistat 150 MG (SCDC, consists of)
- elvitegravir 150 MG (SCDC, consists of)
- tenofovir alafenamide 10 MG (SCDC, consists of)
- cobicistat 150 MG / elvitegravir 150 MG / emtricitabine 200 MG / tenofovir alafenamide 10 MG [Genvoya] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Genvoya (BN, has ingredient)
- cobicistat 150 MG / elvitegravir 150 MG / emtricitabine 200 MG / tenofovir alafenamide 10 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 50090227900
- 61958190101
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1721619 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1721619 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1721619. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.